Immune response in COVID-19: what is next?
Abstract The coronavirus disease 2019 (COVID-19) has been a global pandemic for more
than 2 years and it still impacts our daily lifestyle and quality in unprecedented ways. A …
than 2 years and it still impacts our daily lifestyle and quality in unprecedented ways. A …
[HTML][HTML] The immune response to SARS-CoV-2 and COVID-19 immunopathology–Current perspectives
JL Boechat, I Chora, A Morais, L Delgado - Pulmonology, 2021 - Elsevier
SARS-CoV-2 is a new beta coronavirus, similar to SARS-CoV-1, that emerged at the end of
2019 in the Hubei province of China. It is responsible for coronavirus disease 2019 (COVID …
2019 in the Hubei province of China. It is responsible for coronavirus disease 2019 (COVID …
Immunopathology of SARS-CoV-2 infection: immune cells and mediators, prognostic factors, and immune-therapeutic implications
The present is a comprehensive review of the immunopathology of Covid-19. The immune
reaction to SARS-CoV-2 infection is characterized by differentiation and proliferation of a …
reaction to SARS-CoV-2 infection is characterized by differentiation and proliferation of a …
A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
RN Mohammed, R Tamjidifar, HS Rahman… - Cell Communication and …, 2022 - Springer
Abstract Coronavirus disease (COVID-19) is a viral infectious disease caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. The infection was reported in …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. The infection was reported in …
COVID-19 immunobiology: lessons learned, new questions arise
A Kaklamanos, K Belogiannis, P Skendros… - Frontiers in …, 2021 - frontiersin.org
There is strong evidence that COVID-19 pathophysiology is mainly driven by a
spatiotemporal immune deregulation. Both its phenotypic heterogeneity, spanning from …
spatiotemporal immune deregulation. Both its phenotypic heterogeneity, spanning from …
SARS‐CoV‐2‐mediated immune system activation and potential application in immunotherapy
Y Tan, F Tang - Medicinal research reviews, 2021 - Wiley Online Library
Although novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)‐mediated
pulmonary inflammation has recently attracted great attention, its pathology and …
pulmonary inflammation has recently attracted great attention, its pathology and …
The pathogenesis of coronavirus-19 disease
AC Borczuk, RK Yantiss - Journal of biomedical science, 2022 - Springer
Severe acute respiratory syndrome-associated coronavirus-2 (SARS-CoV-2) is the causal
agent of coronavirus disease-2019 (COVID-19), a systemic illness characterized by variably …
agent of coronavirus disease-2019 (COVID-19), a systemic illness characterized by variably …
Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management
SARS‐CoV‐2 is a novel human coronavirus responsible for the Coronavirus disease 2019
(COVID‐19) pandemic. Pneumonia and acute respiratory distress syndrome are the major …
(COVID‐19) pandemic. Pneumonia and acute respiratory distress syndrome are the major …
Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC)
With a global tally of more than 500 million cases of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infections to date, there are growing concerns about the post …
coronavirus 2 (SARS-CoV-2) infections to date, there are growing concerns about the post …
[HTML][HTML] CoViD-19 immunopathology and immunotherapy
F Chiappelli, A Khakshooy, G Greenberg - Bioinformation, 2020 - ncbi.nlm.nih.gov
New evidence on the T-cell immuno-pathology in patient's with Corona Virus Disease 2019
(CoViD-19) was reported by Diao et al. in MedRxiv (doi: 10.1101/2020.02. 18.20024364)[1] …
(CoViD-19) was reported by Diao et al. in MedRxiv (doi: 10.1101/2020.02. 18.20024364)[1] …